- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder, Underactive in Canada
Total 4320 results
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
CepheidCompletedBladder CancerUnited States, Canada, Netherlands
-
Spectrum Pharmaceuticals, IncCompletedBladder CancerCanada, United States, Poland
-
Achieve Life SciencesPRA Health SciencesCompletedUrologic Neoplasms | Metastatic Bladder Cancer | Urinary Tract NeoplasmsSpain, United States, Canada, Italy, Poland, Germany, France
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
AllerganTARIS Biomedical, Inc.Completed
-
Bioniche Life Sciences Inc.CompletedBladder NeoplasmsCanada, United States
-
Ludwig-Maximilians - University of MunichRecruitingInfections | Urinary Bladder Diseases | Urinary Tract Infections | Bladder Cancer | Infection, Bacterial | Urinary Tract Disease | Infection, Hospital | Infection WoundGermany
-
Trillium Therapeutics Inc.CompletedInterstitial CystitisCanada
-
PhotocureCompletedBladder CancerUnited States, Canada, Austria, Germany, Netherlands
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Boehringer IngelheimCompletedBladder, NeurogenicBelgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI); University of Southern California; NCIC Clinical...TerminatedBladder CancerUnited States, Canada
-
Duramed ResearchCompletedOveractive BladderUnited States, Canada
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerSpain, United States, Canada, France, United Kingdom
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedBladder Urothelial Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States, Canada
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
GlaxoSmithKlineCompletedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States, Canada
-
National Institute of Diabetes and Digestive and...TerminatedInterstitial Cystitis | Painful Bladder SyndromeUnited States, Canada
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
Imbrium TherapeuticsPurdue Pharma LPActive, not recruiting
-
PfizerCompletedOveractive BladderCanada, United States, Costa Rica, Hungary, Slovakia, Spain, Colombia, India, Russian Federation, Ireland, Korea, Republic of, Germany, Sweden, Poland, Bulgaria, Estonia, Brazil, Greece, Latvia, Lithuania, Malaysia, Romania, Singapore, South Africa and more
-
University of AlbertaCanadian Urological AssociationWithdrawn
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingBladder CancerCanada, Spain, United Kingdom
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
PfizerCompletedOveractive BladderKorea, Republic of, Taiwan, Hong Kong, Japan
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
Anthra PharmaceuticalsUnknownBladder CancerUnited States, Canada
-
University of British ColumbiaProvidence Health & Services; International Spinal Research Trust; International...RecruitingSexual Dysfunction, Physiological | Spinal Cord Injuries | Neurogenic Bowel | Neurogenic Bladder | Spinal Cord StimulationCanada
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Urovant Sciences GmbHCompleted
-
Velicept Therapeutics, Inc.CompletedOveractive BladderUnited States
-
Duramed ResearchCompletedStudy to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderUrinary IncontinenceUnited States, Canada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBladder CancerUnited States, Canada
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
AllerganCompletedMultiple Sclerosis | Urinary Incontinence | Neurogenic BladderFrance, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Nektar TherapeuticsBristol-Myers SquibbCompletedNeoplasm Metastasis | Urinary Bladder NeoplasmUnited States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands